Rigenerand started in 2009 as an academic start-up resulting from a joint venture between the researchers at the University of Modena and Reggio Emilia - www.unimore.it & RanD - www.rand-biotech.com Thanks to an investment by Principia SGR SpA, Rigenerand is now a unique enterprise conjugating cGMP-grade cell manufacturing for cells and gene therapies with the design and manufacturing of avant-garde biomedical devices for applications in tissue regeneration and oncology


Rigenerand Srl is combining the know-how in biomedical device manufacturing eradicated in the biomedical district of Mirandola with the lasting expertise of clinical scientists developing cells and gene therapy approaches to target still incurable human diseases

Read more